Substipharm Is An Independent French Pharmaceutical Group Founded In 1995Specializing In The Developmentsupplyand Commercialization Of Generic And Niche Pharmaceutical Productsheadquartered In Paristhe Company Operates Globallywith Subsidiaries In The Ukitalyswitzerlandand Thailandserving Over 80 Countriessubstipharm Has Expanded Through Strategic Acquisitionsincluding Gerda Labs And The Imojevajapanese Encephalitis Vaccineleading To The Establishment Of Substipharm Biologics The Company Offers Comprehensive Pharmaceutical Development Servicesincluding Dossier Developmentregulatory Registrationand Market Launch Supportit Also Licenses Proprietary Dossiers And Manages A Global Supply Chain Through A Network Of Contract Manufacturerssubstipharm S Product Portfolio Includes Over 90 Moleculesfocusing On Difficult To Develop Medicines And Niche Genericswith More Than 50 Ongoing Projectsthe Company Collaborates With Over 20 Leading International Pharmaceutical Companiesproviding Tailored Solutions For Complex Formulations And Enhancing Its Biologics Production Capabilities
No conferences found for this company.
| Company Name | Laboratoire Substipharm |
| Country |
France
|
| Address | 24 Rue Erlanger 75016 Paris France |
| Telephone | Login to View |
| Login to View |
